Sentinel lymph node biopsy in breast cancer

Annals of Oncology

Volumn 13, Issue 10, 2002, Pages 1531-1537

  Bonnema, J ^a   van de Velde, C J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Case selection; Lymphatic mapping; Micrometastases; Sentinel node biopsy

Indexed keywords

DYE; RADIOISOTOPE; TRACER;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; MALE; PALPATION; PATIENT CARE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; REVIEW; SAFETY; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 0036809544     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf319     Document Type: Review

References (66)

1. Cody HS III. Clinical aspects of sentinel node biopsy. Breast Cancer Res 2001; 3: 104-108.
2. Linehan DC, Hill AD, Akhurst T et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 1999; 6: 450-454.
3. McMasters KM, Wong SL, Martin RC et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 200l; 233: 676-687.
4. Wong SL, Edwards MJ, Chao C et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 2001; 192: 684-689.
5. Derossis AM, Fey J, Yeung H et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001; 193: 473-478.
6. Tanis PJ, Nieweg OE, Valdes Olmos RA, Kroon BB. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 2001; 192: 399-409.
7. Borgstein PJ, Meijer S, Pijpers RJ, van Diest PJ. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg 2000; 232: 81-89.
8. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet 1997; 349: 1668-1669.
9. Mariani G, Moresco L, Viale G et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001; 42: 1198-1215.
10. Cody HS III, Fey J, Akhurst T et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 2001; 8: 13-19.
11. Veronesi U, Paganelli G, Galimberti V et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-1867.
12. Sandrucci S, Mussa A. Sentinel lymph node biopsy and axillary staging of T1-T2 N0 breast cancer: a multicenter study. Semin Surg Oncol 1998; 15: 278-283.
13. Jansen L, Doting MH, Rutgers EJ et al. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg 2000; 87: 920-925.
14. Cserni G, Pap SJ. Internal mammary lymph nodes and sentinel node biopsy in breast cancer. Surg Oncol 2001; 10: 25-33.
15. van der Ent FW, Kengen RA, van der Pol HA et al. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 2001; 234: 79-84.
16. Klauber-DeMore N, Bevilacqua JL, Van Zee KJ et al. Comprehensive review of the management of internal mammary lymph node metastases in breast cancer. J Am Coll Surg 2001; 193: 547-555.
17. McMasters KM, Wong SL, Tuttle TM et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 2000; 231: 724-731.
18. Burak WE Jr, Walker MJ, Yee LD et al. Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg 1999; 177: 445-449.
19. Olson JA Jr, Fey J, Winawer J et al. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer. J Am Coll Surg 2000; 191: 593-599.
20. Bedrosian I, Reynolds C, Mick R et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000; 88: 2540-2545.
21. Nason KS, Anderson BO, Byrd DR et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000; 89: 2187-2194.
22. Tanis PJ, Nieweg OE, Merkus JW et al. False negative sentinel node procedure established through palpation of the biopsy wound. Eur J Surg Oncol 2000; 26: 714-715.
23. Pendas S, Dauway E, Giuliano R et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000; 7: 15-20.
24. Klauber-DeMore N, Tan LK, Liberman L et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000; 7: 636-642.
25. Lagios MD, Silverstein MJ. Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol 2001; 8: 275-277.
26. Finck SC, Villela R, Young S et al. An evaluation of micrometastasis in ductal carcinoma in situ (DCIS). Breast Cancer Res Treat 2001; 69: 250 (Abstr).
27. Fernandez A, Cortes M, Benito E et al. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun 2001; 22: 361-366.
28. Haid A, Tausch C, Lang A et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 2001; 92: 1080-1084.
29. Julian TB, Patel N, Dusi D et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2001; 182: 407-410.
30. Breslin TM, Cohen L, Sabin A et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000; 18: 3480-3486.
31. Kuerer HM, Sabin AA, Hunt KK et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 1999; 230: 72-78.
32. Liberman L, Cody HS III. Percutancous biopsy and sentinel lymphadenectomy: minimally invasive diagnosis and treatment of nonpalpable breast cancer. AJR Am J Roentgenol 2001; 177: 887-891.
33. Haigh PI, Hansen NM, Qi K, Giuliano AE. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 2000; 7: 21-27.
34. Schrenk P, Wayand W. Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet 2001; 357: 122.
35. Port ER, Fey JV, Cody HS III, Borgen PI. Sentinel lymph node biopsy in patients with male breast carcinoma. Cancer 2001; 91: 319-323.
36. Tafra L, Lannin DR, Swanson MS et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001; 233: 51-59.
37. Krag D, Weaver D, Ashikaga T et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 1998; 339: 941-946.
38. McMasters KM, Wong SL, Chao C et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg 2001; 234: 292-299.
39. Dupont EL, Kuhn MA, McCann C et al. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 2000; 180: 274-277.
40. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997; 80: 1188-1197.
41. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990; 335: 1565-1568.
42. Cote RJ, Peterson HF, Chaiwun B et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 1999; 354: 896-900.
43. Rampaul RS, Miremadi A, Pinder SE et al. Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Res 2001; 3: 113-116.
44. Torrenga H, Rahusen FD, Meijer S et al. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2001; 54: 550-552.
45. van Diest PJ, Torrenga H, Meijer S, Meijer CJ. Pathologic analysis of sentinel lymph nodes. Semin Surg Oncol 2001; 20: 238-245.
46. Dowlatshahi K, Fan M, Bloom KJ et al. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study. Cancer 1999; 86: 990-996.
47. Turner RR, Chu KU, Qi K et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89: 574-581.
48. Rahusen FD, Torrenga H, van Diest PJ et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg 2001; 136: 1059-1063.
49. Liberman L. Pathologic analysis of sentinel lymph nodes in breast carcinoma. Cancer 2000; 88: 971-977.
50. Grube BJ, Giuliano AE. Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol 2001; 20: 230-237.
51. Bourez RL, Rutgers EJ. The European organization for research and treatment of cancer (EORTC) breast group: quality control of surgical trials. Surg Oncol Clin N Am 2001; 10: 807-819.
52. Singletary SE. Systemic treatment after sentinel lymph node biopsy in breast cancer: who, what, and why? J Am Coll Surg 2001; 192: 220-230.
53. Mansi JL, Gogas H, Bliss JM et al. Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet 1999; 354: 197-202.
54. Bass SS, Cox CE, Ku NN et al. The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg 1999; 189: 183-194.
55. Cox CE, Pendas S, Cox JM et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227: 645-651.
56. Cantin J, Scarth H, Levine M, Hugi M. Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy. CMAJ 2001; 165: 166-173.
57. Lucci A Jr, Kelemen PR, Miller C III et al. National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 2001; 192: 453-458.
58. Schijven M, Rutten H, Roumen R. Implementation of the sentinel node biopsy: a survey among surgeons in the Netherlands. Eur J Surg Oncol 2000; 26: 431-432.
59. Fraile M, Rull M, Julian FJ et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 2000; 11: 701-705.
60. Roy P, Bobin JY, Esteve J. Methodological questions in sentinel lymph node analysis in breast cancer patients. Ann Oncol 2000; 11: 1381-1385.
61. Giuliano AE, Haigh PI, Brennan MB et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000; 18: 2553-2559.
62. Veronesi U, Galimberti V, Zurrida S et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001; 37: 454-458.
63. Roumen RM, Kuijt GP, Liem IH, van Beek MW. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 2001; 88: 1639-1643.
64. Clarke D, Khonji NI, Mansel RE. Sentinel node biopsy in breast cancer: ALMANAC trial. World J Surg 2001; 25: 819-822.
65. Harlow SP, Krag DN. Sentinel lymph node-why study it: implications of the B-32 study. Semin Surg Oncol 2001; 20: 224-229.
66. Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the Consensus Conference on the role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast, April 19-22, 2001, Philadelphia, Pennsylvania.